To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open99
High100.76
Low98.5
Prev. Close98.9
Avg. Traded Price99.26
Volume19,569

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

98.509 hours ago
100.7610 hours ago
arrow

LOWER/UPPER CIRCUITS

79.55
119.32
arrow
Lyka Labs Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 24.92%, in the last year to ₹140.73 Cr. Its sector's average revenue growth for the last fiscal year was 10.53%.
noteAnnual Net Profit,rose 421.84% in the last year to ₹8.01 Cr. Its sector's average net profit growth for the last fiscal year was 37.23%.
noteQuarterly Revenue,rose 9.67% YoY to ₹33.66 Cr. Its sector's average revenue growth YoY for the quarter was 9.69%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 34.56%
Net profit growth 5Y CAGR : 0%
Lyka Labs Limited (Lyka) is an India-based healthcare company. The Company is manufacture of lyophilized products. The primary segment of the Company is business segment which consists of pharmaceutical products /pharma related services. The Company’s Lyophilization facility is at Ankleshwar. The Company’s prospects of lyophilized products are in both formulations and Bulk Drugs which have presence in domestic and international markets.
personal

Grow your wealth with more research recommendations

+91